<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320873">
  <stage>Registered</stage>
  <submitdate>26/11/2009</submitdate>
  <approvaldate>3/02/2010</approvaldate>
  <actrnumber>ACTRN12610000114044</actrnumber>
  <trial_identification>
    <studytitle>A randomized double blind, placebo-controlled clinical trial with oral n-acetylcysteine in systemic sclerosis patients and assessment of skin blood flow of the hands with laser Doppler perfusion imaging</studytitle>
    <scientifictitle>Oral N-acetylcysteine in the Treatment of Raynaud's Phenomenon Secondary to Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>microcirculation</healthcondition>
    <healthcondition>systemic sclerosis</healthcondition>
    <healthcondition>fingertip blood flow</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Connective tissue diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>participants will receive capsules with n-acetylcysteine 600 mg three applications per day orally for 4 weeks to be provided by a developer who did not attend the previous steps</interventions>
    <comparator>the placebo group received capsules containing corn starch at the same dose of n-acetylcysteine and the same physical characteristics</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>improvement finger blood flow by laser Doppler perfusion imaging</outcome>
      <timepoint>blood flow of the fingertips will be evaluated at 0, 1 minute, 4 minutes, 17 minutes, 20 minutes, 10 minutes and 27 minutes before and after cold stimulation at week 1 and at 0, 1 minutes, 4 minutes, 17 minutes, 20 minutes, 10 minutes and 27 minutes after cold stimulation before and after 4 weeks of treatment with n-acetylcysteine or placebo</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>improvement of pain and severity of Raynaud phenomenon by visual analogical scale</outcome>
      <timepoint>30 minutes after cold stimulus before and after 4 weeks of treatment with drug or placebo</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Raynaud phenomenon secondary to systemic sclerosis with pain</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>smokers and diabetes</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>after the election of participants for the study and signing the consent and prior knowledge they were allocated using the minitab softtware per participant who was not involved in other stages of the study.</concealment>
    <sequence>by software minitab</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 0</phase>
    <anticipatedstartdate>25/08/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Sao Paulo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Foundation for the support for research in the state of Sao Paulo</primarysponsorname>
    <primarysponsoraddress>R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 - Sao Paulo/SP - Brasil</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Foundation for the support for research in the state of Sao Paulo</fundingname>
      <fundingaddress>R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 - Sao Paulo/SP - Brasil</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>analyze the effect of oral N-acetylcysteine on microcirculation by laser Doppler perfusion imaging in systemic sclerosis patients</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics committee from Federal University of Sao Paulo</ethicname>
      <ethicaddress>Rua Botucatu, 740, Vila Clementino
Sao Paulo, SP
CEP 04023062</ethicaddress>
      <ethicapprovaldate>6/02/2006</ethicapprovaldate>
      <hrec>1/06/1298</hrec>
      <ethicsubmitdate>5/02/2006</ethicsubmitdate>
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Marcelo Jose Uchoa Correa</name>
      <address>Rua Botucatu, 740, Vila Clementino, Sao Paulo, SP, CEP 04023062</address>
      <phone>+55 11 55796665</phone>
      <fax />
      <email>marcelojucorrea@yahoo.com.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Marcelo Jose Uchoa Correa</name>
      <address>Rua Botucatu, 740, Vila Clementino, Sao Paulo, SP, CEP 04023062</address>
      <phone>+55 11 55796665</phone>
      <fax />
      <email>marcelojucorrea@yahoo.com.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cristiane Kayser</name>
      <address>Rua Botucatu, 740, Vila Clementino, Sao Paulo, SP, CEP 04023062</address>
      <phone>+55 11 55796665</phone>
      <fax />
      <email>criskayser@terra.com.br</email>
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>